C-type natriuretic peptide: New candidate for endothelium-derived hyperpolarising factor

International Journal of Biochemistry and Cell Biology

Volumn 36, Issue 10, 2004, Pages 1878-1881

  Chauhan, S D ^a   Hobbs, A J ^b   Ahluwalia, A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

CNP; EDHF; Endothelial dysfunction

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C PEPTIDE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; POTASSIUM CHANNEL; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTERY COMPLIANCE; ARTERY MUSCLE; BLOOD VESSEL TONE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTHELIUM LESION; MESENTERY BLOOD FLOW; NONHUMAN; RAT; RESISTANCE BLOOD VESSEL; REVIEW;

EID: 2942557131     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2003.09.009     Document Type: Short Survey

References (16)

1. Busse R., Edwards G., Feletou M., Fleming I., Vanhoutte P.M., Weston A.H. EDHF: Bringing the concepts together. Trends in Pharmacological Sciences. 23:2002;374-380
2. Cai H., Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circulation Research. 87:2000;840-844
3. Chauhan S.D., Nilsson H., Ahluwalia A., Hobbs A.J. Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor. Proceedings of the National Academy of Sciences of the United States of America. 100:2003;1426-1431
4. Chen H.H., Burnett J.C. Jr. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system. Journal of Cardiovascular Pharmacology. 32(Suppl. 3):1998;S22-S28
5. Hama N., Itoh H., Shirakami G., Suga S., Komatsu Y., Yoshimasa T., Tanaka I., Mori K., Nakao K. Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients. Biochemistry and Biophysics Research Communications. 198:1994;1177-1182
6. Katz S.D., Krum H. Acetylcholine-mediated vasodilation in the forearm circulation of patients with heart failure: Indirect evidence for the role of endothelium-derived hyperpolarizing factor. American Journal of Cardiology. 87:2001;1089-1092
7. Matsukawa T., Mano T. Atrial natriuretic hormone inhibits angiotensin II-stimulated sympathetic nerve activity in humans. American Journal of Physiology. 271:1996;R464-R471
8. Murthy K.S., Teng B.Q., Zhou H., Jin J.G., Grider J.R., Makhlouf G.M. G(i-1)/G(i-2)-dependent signaling by single-transmembrane natriuretic peptide clearance receptor. American Journal of Physiology. 278:2000;G974-G980
9. + channels in relaxations of hypercholesterolemic rabbit carotid artery to NO. American Journal of Physiology. 269:1995;H805-H811
10. Scotland R.S., Chauhan S., Vallance P.J., Ahluwalia A. An endothelium-derived hyperpolarizing factor-like factor moderates myogenic constriction of mesenteric resistance arteries in the absence of endothelial nitric oxide synthase-derived nitric oxide. Hypertension. 38:2001;833-839
11. Shimokawa H., Yasutake H., Fujii K., Owada M.K., Nakaike R., Fukumoto Y., Takayanagi T., Nagao T., Egashira K., Fujishima M., Takeshita A. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. Journal of Cardiovascular Pharmacology. 28:1996;703-711
12. Sudoh T., Minamino N., Kangawa K., Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochemistry and Biophysics Research Communications. 168:1990;863-870
13. Suga S., Nakao K., Itoh H., Komatsu Y., Ogawa Y., Hama N., Imura H. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of vascular natriuretic peptide system. Journal of Clinical Investigation. 90:1992;1145-1149
14. Suzuki T., Yamazaki T., Yazaki Y. The role of the natriuretic peptides in the cardiovascular system. Cardiovascular Research. 51:2001;489-494
15. Taddei S., Ghiadoni L., Virdis A., Buralli S., Salvetti A. Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients. Circulation. 100:1999;1400-1405
16. Urakami-Harasawa L., Shimokawa H., Nakashima M., Egashira K., Takeshita A. Importance of endothelium-derived hyperpolarizing factor in human arteries. Journal of Clinical Investigation. 100:1997;2793-2799